Depo-Provera Meningioma Symptoms: What to Watch For and When to See a Doctor

Published: March 20, 2026 9 min read

If you used Depo-Provera for two or more years, knowing the symptoms of meningioma could genuinely matter. In August 2024, the FDA added a black box warning linking long-term Depo-Provera use to an increased risk of meningioma, a type of brain tumor. For many women, that warning came decades too late. The symptoms can be subtle and easy to dismiss — but catching them early changes your options.

What Is a Meningioma?

A meningioma is a tumor that grows in the meninges — the three-layer protective tissue surrounding your brain and spinal cord. Most meningiomas are classified as benign (non-cancerous), but that word can be misleading. Even a non-cancerous tumor pressing on brain tissue causes serious neurological problems. Some meningiomas do become malignant, and even "benign" cases often require surgery, radiation, or long-term monitoring.

Meningiomas are the most common primary brain tumor in adults, accounting for roughly 36% of all brain tumors. They grow slowly — sometimes over years or even decades — which is part of why symptoms can be subtle at first and easy to miss or dismiss.

Women are diagnosed with meningioma at about twice the rate of men. Researchers have long suspected hormonal factors play a role, and the link between synthetic progestin hormones like medroxyprogesterone acetate (the active ingredient in Depo-Provera) and meningioma growth has been confirmed in multiple large studies.

How Depo-Provera Is Connected to Meningioma

Research published in the British Medical Journal (BMJ) in 2023 found that women who used high-dose progestins — including medroxyprogesterone acetate — had a 5.6 times higher risk of developing meningioma compared to non-users. The risk was dose-dependent: longer use and higher doses corresponded to significantly elevated risk.

Medroxyprogesterone acetate (MPA) binds to progesterone receptors in brain tissue. Meningioma cells are particularly rich in these receptors. When MPA stimulates these receptors repeatedly over years, it can drive tumor growth. This is the biological mechanism the FDA cited when it issued its 2024 black box warning for Depo-Provera.

Critically, stopping Depo-Provera does not immediately eliminate the risk. Studies show elevated meningioma risk persists for years after the last injection. Women who stopped the drug years ago are still potentially at elevated risk and should know the symptoms.

Early Warning Signs: Depo-Provera Meningioma Symptoms to Know

Because meningiomas grow slowly, early symptoms are often vague. They're easy to chalk up to stress, migraines, aging, or other explanations. If you've used Depo-Provera for two or more years and experience any of the following, they deserve a conversation with your doctor — especially if they're new, worsening, or unexplained.

Headaches

Persistent headaches that feel different from ones you've had before — particularly headaches that are worse in the morning or when lying down, or that don't respond to over-the-counter pain relievers — are one of the most common early signs of a growing meningioma. Headaches caused by meningioma are often described as a dull pressure rather than a sharp pain, and they can develop gradually over months.

Vision Changes

Meningiomas near the front of the skull or the optic nerve can press on the visual pathways, causing:

• Blurred or double vision
• Gradual loss of peripheral (side) vision
• Difficulty reading or tracking text
• Episodes of visual disturbance or "floaters"

Vision changes from meningioma often develop so slowly that women don't realize how much their sight has declined until the problem is identified on imaging.

Hearing Loss or Ringing in the Ears

Tumors near the temporal lobe or at the base of the skull can affect hearing. This may appear as one-sided hearing loss, a persistent ringing or buzzing sound (tinnitus), or a feeling of fullness in one ear. Many women have their hearing tested multiple times before an underlying meningioma is found.

Memory Problems and Cognitive Changes

Difficulty remembering recent events, trouble concentrating, slowed thinking, or finding the right words are all possible early signs of a meningioma pressing on frontal or temporal lobe tissue. These symptoms are often dismissed as stress, anxiety, or early aging — particularly in women in their 40s and 50s.

Smell Loss or Changes

Meningiomas in the olfactory groove — the area above the nose — can cause partial or complete loss of smell. This symptom is particularly sneaky because it develops so gradually. Some women only notice it when food loses flavor or they can't detect a strong odor they used to recognize easily.

Serious Symptoms That Require Immediate Medical Attention

The following symptoms suggest a rapidly growing or large meningioma that needs urgent evaluation. Do not wait for a scheduled appointment if you experience these — go to an emergency room.

• Sudden severe headache — especially one described as "the worst headache of my life"
• Seizures — including any unexplained loss of consciousness, uncontrolled shaking, or staring spells in someone who has never had seizures before
• Weakness or numbness on one side of the body — face, arm, or leg
• Sudden confusion or disorientation
• Difficulty speaking or understanding speech
• Sudden loss of vision in one or both eyes
• Loss of balance or coordination that develops suddenly

How Depo-Provera Meningioma Symptoms Develop Over Time

Understanding the timeline of meningioma symptom development can help you make sense of what you're experiencing. Meningiomas don't appear overnight. Here's how they typically progress:

Years 0–5 after Depo-Provera use begins: The tumor may begin forming, but is too small to cause noticeable symptoms. No symptoms at all.

Years 5–10: The tumor reaches a size where it begins pressing on nearby structures. Intermittent headaches, occasional vision or hearing changes, or subtle cognitive shifts may begin. These are often not connected to Depo-Provera use at this stage.

Years 10+: Symptoms become more consistent and harder to ignore. Medical evaluation may reveal the tumor at this point — sometimes accidentally, during imaging done for another reason.

This long latency period is part of why many women who used Depo-Provera in the 1990s and 2000s are only now being diagnosed. And it's why former Depo-Provera users — not just current users — should be aware of the symptoms.

When to See a Doctor

See a doctor promptly if you:

• Have used Depo-Provera for two or more years (cumulative, not necessarily consecutive)
• Are experiencing any new or worsening headaches that differ from your usual pattern
• Notice any changes in vision, hearing, smell, memory, or coordination
• Have already received a meningioma diagnosis and haven't told your doctor about your Depo-Provera history

When you see your doctor, be specific: tell them how long you used Depo-Provera, when you stopped, and what symptoms you're experiencing. Ask specifically about MRI imaging to rule out a meningioma. A CT scan may miss small meningiomas — an MRI with contrast is the gold standard for diagnosis.

You should also tell your doctor about the FDA's August 2024 black box warning for Depo-Provera if they seem unfamiliar with it. Providing context can help them order the right tests.

How Meningioma Is Diagnosed

Meningioma is diagnosed through brain imaging, not blood tests or physical exams. The process typically looks like this:

Step 1: MRI with contrast. A gadolinium-enhanced MRI of the brain is the most reliable way to detect a meningioma. The contrast agent makes the tumor visible on the scan. Most meningiomas appear as a bright, well-defined mass attached to the meninges.

Step 2: Neurosurgical consultation. If a meningioma is found, you'll be referred to a neurosurgeon or neuro-oncologist who will review the imaging, discuss the tumor's location and size, and recommend a management plan. Not all meningiomas require immediate surgery — some are monitored with periodic MRIs.

Step 3: Pathology (if surgery is performed). If the tumor is removed, the tissue is sent to a lab for pathological analysis to determine the grade (I, II, or III) and whether it's benign or malignant.

Step 4: Ongoing monitoring. Even after successful treatment, follow-up MRIs are typically required every 1–3 years. Meningiomas can recur, particularly higher-grade tumors.

Your Legal Rights If You Have Depo-Provera Meningioma Symptoms

If you used Depo-Provera for two or more years and have been diagnosed with meningioma, you may have the right to file a legal claim against the manufacturer. MDL 3140 — the federal Depo-Provera meningioma litigation — currently has over 1,700 active cases consolidated in the Northern District of Illinois. Filing a claim does not require you to go to court, and many attorneys handle these cases on contingency, meaning no upfront cost to you.

The statute of limitations (the legal deadline to file) varies by state, but many run from the date you first discovered — or reasonably should have discovered — that Depo-Provera caused your injury. For many women, that clock started with the FDA's August 2024 warning. Don't wait too long to find out where you stand.

For more information on whether you may qualify, see our guide: Do I Qualify for a Depo-Provera Lawsuit? and our 2026 Lawsuit Update. You can also read about how to file a Depo-Provera claim.